An interventional study of Exercise training in Congenital Heart Defect, Congenital Heart Disease and Microvascular Dysfunction, sponsored by University Hospital, Antwerp. Completed at 1 site in Belgium. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-04.
Sponsored by University Hospital, Antwerp · Not applicable, Interventional, and Treatment
The goal of this prospective cohort study is to deepen the understanding of the pathophysiology in adults with congenital heart disease (CHD). Through this research, the investigators aim to identify potential strategies to improve the prevention and treatment of these patients. In this context, the effects of exercise training will also be assessed. The main questions it aims to answer are:
For the last research question, patients were randomized to receive either conventional care or home-based aerobic and strength exercise training.
1,031 studies on the registry are indexed under Heart Defects, Congenital; 262 are open to participants now.
This study's enrollment of 55 is close to the median of 60 across 531 interventional studies indexed under Heart Defects, Congenital.
Browse Heart Defects, Congenital studies →University Hospital, Antwerp is the lead sponsor of 242 studies on the registry; 69 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Each participant received a personalized rehabilitation schedule combining aerobic interval cycle training and a dynamic strength exercise program, developed to ensure that the participants met the physical activity guidelines.
Behavioral: Exercise training
In the conventional care arm, patients did not receive explicit exercise advice but were provided with general information regarding a healthy lifestyle, in accordance with current physical activity guidelines during the first study visit.
Each participant received a personalized rehabilitation schedule combining aerobic interval cycle training and a dynamic strength exercise program, developed to ensure that the participants met the physical activity guidelines. For the aerobic training, the patients cycled for 30-45 minutes on an exercise bike at home 3 times a week. During each training session, the heart rate (HR) was continuously recorded using a chest strap and displayed in a smartphone application. The target HR zones were predefined with alternating intervals of intensive and extensive aerobic training. The program followed a progressive structure with the objective of completing 40 minutes of intensive aerobic training after 16 weeks. In the strength training program, 4 dynamic exercises targeting major muscle groups were performed 3 times a week. Every 2 weeks, these exercises were intensified by altering the starting position or adding extra weight.
Also known as: Exercise program, Home-based aerobic and strength exercise program, Training program, Exercise training progam
Coronary microvascular function: coronary flow reserve
The coronary flow reserve (CFR) was measured using pulsed wave Doppler measurements at the mid to distal left anterior descending artery (LAD) in an apical modified 2-chamber view. At baseline and during hyperemia (following a 3-minute period of intravenous adenosine administration at a rate of 140 µg/kg/min), three optimal profiles of peak diastolic Doppler flow velocities were measured, and the results were averaged. CFR was then calculated as the ratio between hyperemic and basal average peak velocities.
Time frame: on both study visits (at baseline and at 16 weeks)
Peripheral microvascular function: reactive hyperemia index
Peripheral microvascular function was measured by peripheral arterial tonometry (PAT)(Endo-PAT2000®, Itamar Medical, software version 3.2.4, Caesarea, Israel). Relative ischemia was provoked by inflating a blood pressure cuff on the forearm to a minimum of 100 mmHg above systolic blood pressure. Following a 5-minute period, reactive hyperemia was induced by rapidly deflating the cuff. The reactive hyperemia index (RHI) is defined as the ratio of the average amplitude of the PAT signal over a one-minute period starting one minute after cuff deflation (maximum pulse amplitude) divided by the average amplitude of the PAT signal over a 3.5 minute period preceding cuff inflation (baseline pulse amplitude). RHI and Framingham modified RHI (fRHI) were calculated by dedicated software (Itamar Medical).
Time frame: on both study visits (at baseline and at 16 weeks)
Peripheral microvascular function: Framingham modified reactive hyperemia index
Peripheral microvascular function was measured by peripheral arterial tonometry (PAT)(Endo-PAT2000®, Itamar Medical, software version 3.2.4, Caesarea, Israel). Relative ischemia was provoked by inflating a blood pressure cuff on the forearm to a minimum of 100 mmHg above systolic blood pressure. Following a 5-minute period, reactive hyperemia was induced by rapidly deflating the cuff. The reactive hyperemia index (RHI) is defined as the ratio of the average amplitude of the PAT signal over a one-minute period starting one minute after cuff deflation (maximum pulse amplitude) divided by the average amplitude of the PAT signal over a 3.5 minute period preceding cuff inflation (baseline pulse amplitude). RHI and Framingham modified RHI (fRHI) were calculated by dedicated software (Itamar Medical).
Time frame: on both study visits (at baseline and at 16 weeks)
Carotid arterial wall thickness: carotid intima-media thickness
The carotid intima-media thickness (IMT) was measured: B-mode and color Doppler ultrasound, equipped with a 10 MHz linear array transducer (Aloka Prosound 6 Ultrasound Linear Probe LN 5413, Hitachi Aloka Medical, Japan) was used to evaluate the right common, internal and external carotid arteries. A standardized protocol was applied to evaluate carotid IMT: briefly, all subjects were examined in a supine position with their head turned 45 degrees from the site being scanned. Measurements were made using automated e-tracking of the wall along a distance of 2 cm. Three measurements were taken at the common carotid artery, approximately 2 cm proximal to the carotid bifurcation, and the values were averaged to determine the mean IMT.
Time frame: on both study visits (at baseline and at 16 weeks)
Large artery stiffness: pulse wave velocity
Systemic large artery stiffness was measured using pulse wave velocity (PWV) and augmentation index (AIx)(Sphygmocor system®, AtCor Medical, West Ryde, Australia). For PWV, an applanation tonometer (Millar Instruments) was positioned on both the right common carotid artery and the right femoral artery. Proximal (i.e., carotid) and distal (i.e., femoral) pulses were recorded consecutively and were averaged. PWV was calculated as the carotid-to-distal path length divided by the transit time. In order to prevent overestimation, a scaling factor of 0.8 was applied to convert PWV values obtained using the direct carotid-femoral distance to the corrected PWV (PWVc).
Time frame: on both study visits (at baseline and at 16 weeks)
Large artery stiffness: augmentation index
Systemic large artery stiffness was measured using pulse wave velocity (PWV) and augmentation index (AIx)(Sphygmocor system®, AtCor Medical, West Ryde, Australia). For central AIx, three measurements were obtained using the applanation tonometer (Millar Instruments) at the level of the right carotid artery. AIx was determined as the ratio of augmentation (which is attributed to wave reflection) to pulse pressure (defined as the difference between systolic and diastolic pressure).
Time frame: on both study visits (at baseline and at 16 weeks)
Inflammation: white blood cell count
Fasting peripheral blood was collected using ethylenediaminetetraacetic acid (EDTA) tubes (BD Vacutainer®, Canada). EDTA samples were analyzed using a Sysmex XN-9100 (Sysmex, Germany) to quantify white blood cell counts.
Time frame: on both study visits (at baseline and at 16 weeks)
Inflammation: high-sensitivity C-reactive protein
Fasting peripheral blood was collected using serum vacuette tubes (BD Vacutainer®, Canada). Serum samples were analyzed using an Atellica® IM/CH Analyzer (Siemens Healthcare, Germany) to quantify high-sensitivity C-reactive protein (hs-CRP) concentrations.
Time frame: on both study visits (at baseline and at 16 weeks)
Oxidative stress: superoxide anion radical
Superoxide anion radical levels were quantified using electron paramagnetic resonance (EPR) spectroscopy. When fasting venous blood samples from the patients were obtained in a heparin tube (BD vacutainer®, Canada), 100 µl of blood was immediately added to 100 µL of spin probe CMH. Immediately after mixing, the sample was snap frozen and stored at -80°C until analysis. For analysis conducted at the University of Maastricht (Department of Toxicogenomics), the mixture of CMH and blood was thawed and transferred into a 50 μl glass capillary (Hirschmann®, Germany). The glass capillaries were placed in the resonator of the EPR. EPR measurements were carried out on a Bruker EMX 1273 spectrometer equipped with an ER 4119HS high-sensitivity resonator and 12 kW power supply operating at X band frequencies. The data were analyzed using WinEPR (Brüker, Germany) software and radicals were identified and quantified as ESR peak amplitude arbitrary units (A.U.).
Time frame: on both study visits (at baseline and at 16 weeks)
Left ventricular function: ejection fraction
All echocardiographic examinations were performed by two experienced sonographers utilizing harmonic imaging on an EPIQ7 ultrasound system (Philips Medical Systems, Best, the Netherlands). A detailed 2D transthoracic echocardiogram was performed with the patient placed in the left lateral decubitus position. For the assessment of left ventricular (LV)\* systolic function, LV ejection fraction (LVEF) was measured using the Simpson biplane method. \* The term "LV" refers to the morphological LV
Time frame: on both study visits (at baseline and at 16 weeks)
Left ventricular function: global longitudinal strain
All echocardiographic examinations were performed by two experienced sonographers utilizing harmonic imaging on an EPIQ7 ultrasound system (Philips Medical Systems, Best, the Netherlands). A detailed 2D transthoracic echocardiogram was performed with the patient placed in the left lateral decubitus position. For the assessment of left ventricular (LV)\* systolic function, LV global longitudinal strain (LV GLS) was calculated by combining 3 apical longitudinal LV chamber views (2-, 3- and 4-chamber). \* The term "LV" refers to the morphological LV
Time frame: on both study visits (at baseline and at 16 weeks)
Right ventricular function: fractional area change
The right ventricle (RV)\* was comprehensively assessed using the novel two-dimensional multiplane echocardiography (2D MPE) approach revealing 4 RV views: a focused, non-foreshortened RV view (4C), coronary sinus view (CS), aortic view (Ao) and coronal view (CV). RV fractional area change (FAC)(calculated as: (end-diastolic-end-systolic area)/end-diastolic area x100) was recorded in all 4 RV views. In addition to the values from the individual RV walls, a multiwall average was computed when measurements from at least 3 walls of one individual were feasible to obtain. \* The term "RV" refers to the morphological RV
Time frame: on both study visits (at baseline and at 16 weeks)
Right ventricular function: tricuspid annular plane systolic excursion
The right ventricle (RV)\* was comprehensively assessed using the novel two-dimensional multiplane echocardiography (2D MPE) approach revealing 4 RV views: a focused, non-foreshortened RV view (4C), coronary sinus view (CS), aortic view (Ao) and coronal view (CV). RV tricuspid annular plane systolic excursion (TAPSE)(measured with 2D echocardiography-guided M-mode) was recorded in all 4 RV views. In addition to the values from the individual RV walls, a multiwall average was computed when measurements from at least 3 walls of one individual were feasible to obtain. \* The term "RV" refers to the morphological RV
Time frame: on both study visits (at baseline and at 16 weeks)
Right ventricular function: tissue Doppler imaging systolic velocity
The right ventricle (RV)\* was comprehensively assessed using the novel two-dimensional multiplane echocardiography (2D MPE) approach revealing 4 RV views: a focused, non-foreshortened RV view (4C), coronary sinus view (CS), aortic view (Ao) and coronal view (CV). RV tissue Doppler imaging systolic velocity (TDI S') was recorded in all 4 RV views. In addition to the values from the individual RV walls, a multiwall average was computed when measurements from at least 3 walls of one individual were feasible to obtain. \* The term "RV" refers to the morphological RV
Time frame: on both study visits (at baseline and at 16 weeks)
Right ventricular function: peak systolic global longitudinal strain
The right ventricle (RV)\* was comprehensively assessed using the novel two-dimensional multiplane echocardiography (2D MPE) approach revealing 4 RV views: a focused, non-foreshortened RV view (4C), coronary sinus view (CS), aortic view (Ao) and coronal view (CV). Peak systolic global longitudinal RV strain (RV LS) was assessed in 3 of the 4 RV views (i.e., 4C, CS, Ao) using an automated strain software (AutoStrain; Philips Medical Systems, Best, the Netherlands). In each RV view, a single RV free wall strain value was derived from the average of 3 segments (basal, mid and apical). A multiwall average was calculated if at least 2 RV free walls were feasible to measure. \* The term "RV" refers to the morphological RV
Time frame: on both study visits (at baseline and at 16 weeks)
Quality of life: RAND 36-Item Health Survey 1.0
The patients were asked to complete a quality of life questionnaire consisting of a combination of the RAND 36-Item Health Survey 1.0 and the EuroQol visual analogue scale (EQ-VAS). The RAND 36-Item Health Survey 1.0 encompasses 8 health domains: physical functioning, bodily pain, role limitations due to physical health issues, role limitations due to personal or emotional concerns, general mental health, social functioning, energy/fatigue, and general health perception. Additionally, it incorporates a single item aimed at assessing perceived change in health.
Time frame: on both study visits (at baseline and at 16 weeks)
Quality of life: EuroQol visual analogue scale
The patients were asked to complete a quality of life questionnaire consisting of a combination of the RAND 36-Item Health Survey 1.0 and the EuroQol visual analogue scale (EQ-VAS). The EQ-VAS is a vertical scale to self-rate the patients' current health state, ranging from 0 (worst imaginable) to 100 (best imaginable).
Time frame: on both study visits (at baseline and at 16 weeks)
Exercise capacity: percent-predicted peak oxygen consumption
A cardiopulmonary exercise test was conducted until maximal exhaustion. Therefore, a continuously incrementing ramp protocol (increase of work rate, e.g., every 2-15 seconds) was implemented with the objective of achieving maximal exertion within 8-12 minutes using a Lode Corival bike ergometer. The protocol was chosen based on the Jones' predictions of maximal power output. Throughout the test, gas exchange measurements and 12-lead electrocardiogram readings were continuously recorded, while blood pressure was monitored every minute. Peak oxygen consumption (pVO2) was determined as the mean VO2 during the final 30 seconds of exercise. Subsequently, percent-predicted peak oxygen consumption (%ppVO2) was computed, using the reference values following Wasserman et al. and the LowLands registry.
Time frame: on both study visits (at baseline and at 16 weeks)
Muscle strength: one-repetition maximum
The one-repetition maximum (1RM) was measured for 4 different exercises targeting major muscle groups: chest press, vertical traction, low row, and leg press (BioCircuit Series 4, TechnoGym®, Benelux).
Time frame: on both study visits (at baseline and at 16 weeks)
Plan to share: No
Ran from Jan 2021 to primary completion in Mar 2024, 38 months.
Of 220 non-industry interventional studies with no phase under Heart Defects, Congenital, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 51. This study's 38 months is above that.
Counting every sponsor, half of 241 studies reached it within 33 months; a quarter within 17 and three quarters within 52.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Antwerp →